Synthesis and evaluation of a novel series of N,N-dimethylisotryptamines.
Richard A Glennon, John M. Jacyno, R Young, J D Mckenney, D Nelson
Journal of Medicinal Chemistry January 1984 DOI: 10.1021/jm00367a008 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical pharmacology study Peer reviewed |
|---|---|
| Population | Rats (rat fundus tissue, rat brain cortex homogenates, and rats in a drug discrimination paradigm) |
| Interventions | 6-OMe-isoDMT 5-OMe-DMT DOM isoDMT derivatives DMT derivatives |
| Measures | serotonin receptor affinity (rat fundus), [3H]-5-HT binding displacement from rat brain cortex homogenates, drug discrimination paradigm |
| Key points | isoDMT derivatives showed greater serotonin receptor affinity than corresponding DMT derivatives in rat fundus, yet were relatively ineffective at displacing [3H]-5-HT binding from rat brain cortex homogenates. In rats, 6-OMe-isoDMT produced discriminative stimulus effects similar to 5-OMe-DMT, and two isoDMT derivatives failed to antagonize DOM's discriminative stimulus effects. |
Abstract
A novel series of N,N-dimethylisotryptamine (isoDMT) derivatives, i.e., derivatives of 1-[2-(dimethylamino)ethyl]indole, was prepared and found to be isosteric with their corresponding N,N-dimethyltryptamine (DMT) counterparts with respect to serotonin receptor (rat fundus) affinity. Whereas the isoDMT derivatives possessed a greater affinity than did their corresponding DMT derivatives, they were relatively ineffective in displacing [3H]-5-HT binding from rat brain (cortex) homogenates. In a drug discrimination paradigm, using rats as subjects, 6-OMe-isoDMT produced effects similar to those of 5-OMe-DMT. Attempts to antagonize the discriminative stimulus effects of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) using two of the isoDMT derivatives proved unsuccessful.
Citations in the library
Cited by 6
- Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants Chemical Reviews November 30, 2023
- Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential Proceedings of the National Academy of Sciences April 14, 2025
- Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties. Psychopharmacology May 14, 2024
- Modification of natural tryptamines for the treatment of neuropsychiatric diseases Journal of Psychopharmacology October 4, 2025
- The Emergence of Isotryptamine Analogs as Novel Serotonergic Agents with Psychotherapeutic Potential ACS Pharmacology & Translational Science August 18, 2026
and 1 more in the library